Differences Between APOE Carriers and Non-APOE Carriers on Neurocognitive Tests: Jensen Effects?

doi:10.1177/1533317518765895

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Differences Between APOE Carriers and Non-APOE Carriers on Neurocognitive Tests: Jensen Effects?

American journal of Alzheimer's disease and other dementias - 1 Sept 2018

Nijenhuis Jan Te, Choi Kyu Yeong, Choi Yu Yong, Lee Jang Jae, Seo Eun Hyun, Kim Hoowon, Lee Kun Ho

Abstract excerpt

BACKGROUND: Being a carrier of the apolipoprotein E (APOE) ε4 allele is a clear risk factor for development of Alzheimer's disease (AD). On some neurocognitive tests, there are smaller differences between carriers and noncarriers, while other tests show larger differences. AIMS: We explore whether the size of the difference between carriers and noncarriers is a function of how well the tests measure general...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Risk Factors
Share to Aged
Share to Alzheimer Disease
Share to Apolipoprotein E4

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cognitive Dysfunction

Share to Genotype

Share to Neuropsychological Tests

Share to Republic of Korea

Source

Open in PubMed Open full text

Identifiers

PMID: 29607654
DOI: 10.1177/1533317518765895
PMCID: PMC10852421

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.